Hans Lennart Jeppsson

Chief Financial Officer

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
2
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Jan 9, 2019 – Jul 6, 2026

Hans Lennart Jeppsson reported 11 transactions between Jan 9, 2019 and Jul 6, 2026. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
84.6K SEK
$42
5 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
11
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Vicore Pharma Holding AB shares between Jun 12, 2026 and Jul 8, 2026

Cluster buying

4 different insiders made 4 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

4 insiders bought Vicore Pharma Holding AB shares between Jun 12, 2026 and Jul 8, 2026
Date Insider Transaction Shares Price Value Filing
Jun 12, 2026 peter guenter SACQ Acquisition 160,220 10.56 SEK 1,691,966 SEK FI filing ↗
Jul 6, 2026 Hans Lennart Jeppsson SACQ Acquisition 3 $13.90 $42 FI filing ↗
Jul 6, 2026 Ahmed Mousa SACQ Acquisition 670 $14.90 $9,983 FI filing ↗
Jul 8, 2026 Yasir Al-Wakeel SACQ Acquisition 363 $13.79 $5,006 FI filing ↗

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 11 most recent rows are grouped into 8 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Vicore Pharma Holding AB SACQ Acquisition 3 shares $42 at $13.90 FI filing ↗
  2. Vicore Pharma Holding AB SALL Allotmentnot a buy/sell decision 444 shares 3.1K SEK at 7.00 SEK FI filing ↗
  3. Vicore Pharma Holding AB SSUB Subscriptionnot a buy/sell decision 5,000 shares 35.0K SEK at 7.00 SEK FI filing ↗
  4. Vicore Pharma Holding AB SALL Allotmentnot a buy/sell decisionreported at zero 75,000 shares 0 SEK at 0.00 SEK FI filing ↗
  5. Vicore Pharma Holding AB SALL Allotmentnot a buy/sell decisionreported at zero 50,000 shares 0 SEK at 0.00 SEK FI filing ↗
  6. Vicore Pharma Holding AB SALL Allotmentnot a buy/sell decisionreported at zero 50,000 shares 0 SEK at 0.00 SEK FI filing ↗
  7. Vicore Pharma Holding AB SALL Allotmentnot a buy/sell decisionreported at zero 100,000 shares 0 SEK at 0.00 SEK FI filing ↗
  8. Vicore Pharma Holding AB SACQ Acquisition × 4 5,000 shares 84.6K SEK
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,727 17.00 SEK 29.4K SEK FI filing ↗
    273 17.00 SEK 4.6K SEK FI filing ↗
    77 16.85 SEK 1.3K SEK FI filing ↗
    2,923 16.85 SEK 49.3K SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Vicore Pharma Holding AB SE0007577895 VICORE PHARMA HOLDING AB 5,000 — — FI marknadssok.fi.se ↗
Vicore Pharma Holding AB US92581R1041 Vicore Pharma Holding ADR 3 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Hans Lennart Jeppsson reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.